BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 9727383)

  • 1. Alport syndrome and thin glomerular basement membrane disease.
    Kashtan CE
    J Am Soc Nephrol; 1998 Sep; 9(9):1736-50. PubMed ID: 9727383
    [No Abstract]   [Full Text] [Related]  

  • 2. Alport's syndrome, Goodpasture's syndrome, and type IV collagen.
    Hudson BG; Tryggvason K; Sundaramoorthy M; Neilson EG
    N Engl J Med; 2003 Jun; 348(25):2543-56. PubMed ID: 12815141
    [No Abstract]   [Full Text] [Related]  

  • 3. Goodpasture's disease and Alport's syndromes.
    Turner AN; Rees AJ
    Annu Rev Med; 1996; 47():377-86. PubMed ID: 8712789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathology of glomerular basement membrane nephropathy.
    Hudson BG; Kalluri R; Tryggvason K
    Curr Opin Nephrol Hypertens; 1994 May; 3(3):334-9. PubMed ID: 7922261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thin basement membrane nephropathy: is there genetic predisposition to more severe disease?
    Deltas C
    Pediatr Nephrol; 2009 Apr; 24(4):877-9. PubMed ID: 19018577
    [No Abstract]   [Full Text] [Related]  

  • 6. Spectrum of collagen type IV nephropathies: from thin basement membrane nephropathy to Alport syndrome.
    Vizjak A; Ferluga D
    Srp Arh Celok Lek; 2008 Dec; 136 Suppl 4():323-6. PubMed ID: 20804103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alport disease: a review of the diagnostic difficulties.
    Meleg-Smith S
    Ultrastruct Pathol; 2001; 25(3):193-200. PubMed ID: 11465475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current developments in the diagnosis of Alport syndrome].
    Schröder CH; Lemmink HH; van den Heuvel LP; Smeets HJ
    Ned Tijdschr Geneeskd; 1995 Jan; 139(2):66-9. PubMed ID: 7838220
    [No Abstract]   [Full Text] [Related]  

  • 9. Alport syndrome diagnosed by immunofluorescence using a new monoclonal antibody.
    Kiyatake I; Tomino Y; Shirato I; Nakayama S; Koide H
    Intern Med; 1993 Jan; 32(1):26-30. PubMed ID: 8495040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Collagen type IV nephropathy: from thin basement membrane nephropathy to Alport syndrome].
    Endreffy E; Ondrik Z; Kemény E; Vas Z; Maróti Z; Lencse G; Bereczki C; Haszon I; Túri S; Iványi B
    Orv Hetil; 2005 Dec; 146(52):2647-53. PubMed ID: 16468607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An unusual case of pulmonary-renal syndrome associated with defects in type IV collagen composition and anti-glomerular basement membrane autoantibodies.
    Charytan D; MacDonald B; Sugimoto H; Pastan S; Staton G; Hennigar R; Kalluri R
    Am J Kidney Dis; 2005 Apr; 45(4):743-8. PubMed ID: 15806477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential diagnosis between X-linked Alport syndrome and thin basement membrane nephropathy.
    Rizzoni G; Massella L
    Kidney Int; 2004 Sep; 66(3):1289-90; author reply 1290. PubMed ID: 15327434
    [No Abstract]   [Full Text] [Related]  

  • 13. Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome.
    Kashtan CE; Butkowski RJ; Kleppel MM; First MR; Michael AF
    J Lab Clin Med; 1990 Oct; 116(4):508-15. PubMed ID: 2212860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial hematuric syndromes--Alport syndrome, thin glomerular basement membrane disease and Fechtner/Epstein syndromes.
    Kashtan CE
    Contrib Nephrol; 2001; (136):79-99. PubMed ID: 11688406
    [No Abstract]   [Full Text] [Related]  

  • 15. X-linked Alport syndrome with normal distribution of collagen IV alpha chains in epidermal basement membrane.
    Naito I; Nomura S; Inoue S; Kagawa M; Matsubara T; Araki T; Taki M; Ohmori H; Manabe K; Kawai S; Osawa G; Sado Y
    Contrib Nephrol; 1997; 122():134-9. PubMed ID: 9399056
    [No Abstract]   [Full Text] [Related]  

  • 16. Targets of alloantibodies in Alport anti-glomerular basement membrane disease after renal transplantation.
    Brainwood D; Kashtan C; Gubler MC; Turner AN
    Kidney Int; 1998 Mar; 53(3):762-6. PubMed ID: 9507224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 5 COLIV chain distribution in glomerular basement membrane in a male with X-linked Alport syndrome and thin basement membrane.
    Rizzoni G; Massella L; Muda AO
    Pediatr Nephrol; 2000 Dec; 15(3-4):325. PubMed ID: 11149132
    [No Abstract]   [Full Text] [Related]  

  • 18. Type IV collagen alpha 5 chain. Normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody.
    Yoshioka K; Hino S; Takemura T; Maki S; Wieslander J; Takekoshi Y; Makino H; Kagawa M; Sado Y; Kashtan CE
    Am J Pathol; 1994 May; 144(5):986-96. PubMed ID: 8178947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular and functional defects in kidneys of mice lacking collagen alpha 3(IV): implications for Alport syndrome.
    Miner JH; Sanes JR
    J Cell Biol; 1996 Dec; 135(5):1403-13. PubMed ID: 8947561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome.
    Cosgrove D; Liu S
    Matrix Biol; 2017 Jan; 57-58():45-54. PubMed ID: 27576055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.